UNSPSC 85552966: Alteration of right upper eyelid with autologous tissue substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to alteration of right upper eyelid with autologous tissue substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 080N37Z

UNSPSC 85552966 Alteration of right upper eyelid with autologous tissue substitute, percutaneous approach is a Commodity code that shows little relevant recent activity under state and local procurement. The code nominally describes a specific surgical procedure, but the six opportunities posted since mid-July 2026 reflect procurement of occupational health surveillance, independent medical evaluations, pharmacy benefit management, surgical carve-out networks, temporary health professional staffing, and emergency medical services for detained youth — none of which align with eyelid reconstruction or tissue-substitute surgery. This mismatch suggests the code was either misapplied to these solicitations or captures administrative medical services rather than the surgical procedure its name implies. State and local procurement offices do not appear to be soliciting the specific procedure described by the code.

The recent opportunities instead reflect broader health services procurement by county health systems, municipal retirement offices, state transportation departments, and county juvenile justice agencies across Arizona, California, Florida, and Washington. The City of Phoenix Retirement Office solicited independent medical evaluation services through an RFP due October 16, 2026; the Washington State Department of Transportation sought occupational medical surveillance services with proposals due October 9, 2026; and the County of Santa Clara Health System established a qualified vendor pool for temporary health professional staffing with responses due October 7, 2026. Without evidence of actual state and local procurement under this Commodity code for eyelid surgery or tissue-substitute procedures, the code warrants a skip for business development purposes targeting procedure-specific surgical services.